Recent studies have also indicated that through interaction with PP2A, SET upregulates androgen biosynthesis [34] and contributes to hyperandrogenism in polycystic ovary syndrome (PCOS) and to gynecologycal cancers, as reviewed by Jiang et al. [93,115]. The gene discussed is PTPA; the disease is polycystic ovary syndrome.